Skip to main content
VCbacked
Log inGet Started

Accession Therapeutics

Oxford, United Kingdom

Accession Therapeutics is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumor diversity.

$31.3M raised
Apr 2024
Venture - Series Unknown
BiopharmaBiotechnology

Top Investors

Primavera Capital GroupiGlobe PartnersBirk Venture

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Accession Therapeutics

How much funding has Accession Therapeutics raised?
Accession Therapeutics has raised $31.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2024.
Who are Accession Therapeutics's investors?
Accession Therapeutics's investors include Primavera Capital Group, iGlobe Partners, Birk Venture.
Where is Accession Therapeutics headquartered?
Accession Therapeutics is headquartered in Oxford, United Kingdom.
What does Accession Therapeutics do?
Accession Therapeutics is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumor diversity.
What stage is Accession Therapeutics at?
Accession Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Accession Therapeutics — Funding & Investors." VCBacked, April 25, 2024, https://www.vcbacked.co/company/accession-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2024). Accession Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/accession-therapeutics
Wikipedia (cite web)
{{cite web |title=Accession Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/accession-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M